Istios Health Announces a $5.6M Seed Funding Round Led by BIP Ventures

FOR IMMEDIATE RELEASE

PHOENIX, AZ – June 19, 2025 – (June 2025)

Istios Health Announces a $5.6M Seed Funding Round Led by BIP Ventures

The Funding Accelerates the Company’s Mission to Transform Infectious Disease Care and Therapeutic Discovery

Istios Health Inc., a healthcare technology company focused on infectious disease (ID) care, has closed a $5.6 million seed funding round led by BIP Ventures, with participation from RVM Enterprises—the family office of Dr. Roger Medel, founder and former CEO of Pediatrix (NYSE: MD). Dr. Medel will join the Istios Board of Directors as Chairman.

“We are excited to partner with BIP Ventures, which has deep experience in health technology and solutions,” said Nikos Nikolopoulos, CEO and co-founder of Istios Health. “We have put together a world-class team of business and clinical professionals to build out a high-performing integrated physician and clinical site network powered by our real-world data and physician enablement platform called ID Navigator.”

Over 80% of U.S. counties lack access to an ID specialist. Meanwhile, rising antimicrobial resistance, sepsis, and emerging infections are increasing the burden of disease. Yet the infrastructure for ID clinical trials remains fragmented, slowing innovation in diagnostics and therapeutics.

To accelerate its strategy, Istios has merged with NoD MD (d/b/a NoD Health), a pioneer in tele-infectious disease consults. NoD’s founder, Dr. Madhu Murthy, now serves as an Istios co-founder and Head of Clinical Partnerships, as well as sitting on the Board of Directors for the company.

“By joining forces with Istios and building a platform that integrates care delivery with clinical research and real-world data, we have the opportunity to fundamentally reshape how infectious diseases are treated, studied, and prevented at a national scale,” said Dr. Murthy.

Nick Carlucci, co-founder and COO, added, “We are building the operating system for infectious disease, designed to improve patient care and physician satisfaction. From rural hospitals to biotech sponsors, our infectious disease platform connects the dots for smarter care, better research, and stronger outcomes.”

“As experienced investors in healthcare tech, we understand the critical problem Istios Health is positioned to solve. We understand how their integrated model can revolutionize infectious disease care and trial discovery,” said Austin Poole, General Partner of BIP Ventures. “We’re thrilled to partner with this accomplished, focused team. We have every reason to believe this team has the experience, vision, ability, and resources to deliver innovation across clinical care and research.”

The funding will support platform expansion, physician network growth, and product commercialization of a Real-World Evidence (RWE) data platform.

About
About Istios Health (dba Nod Health)

Istios Health, doing business as Nod Health, is a healthcare technology and services company focused on delivering virtual infectious disease care, enabling physician collaboration, and accelerating clinical research through a nationwide, tech-enabled ID network. Founded by physicians and digital health operators, the company combines telehealth, real-world evidence, and clinical infrastructure to improve care quality, expand access, and drive innovation in ID medicine. Visit www.nod.health to learn more.

Contact:
Full Name: Nikos Nikolopoulos
Title: Co-founder, CEO
Company Name: Istios Health
Website: https://www.istios.health/

Keywords:
Funding, Investing, HealthTech, Healthcare, Infectious Disease, Venture Capital, BIP Ventures, Istios Health, Nod Health, NoD MD, Pediatrix

Tickers:
NYSE: MD